Revolution Medicines, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/07/2025 | 15.66 M | $731.47 M | -0.63% | 8.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2025 | 14.63 M | $683.02 M | 2.09% | 7.77% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 11.36 M | $530.31 M | 7.23% | 6.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 9.81 M | $458.29 M | -4.35% | 5.22% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 9.46 M | $441.57 M | 0.97% | 5.03% |
| FMR LLC | 11/13/2025 | 9.40 M | $439.06 M | 12.93% | 5.00% |
| BLACKROCK, INC. | 11/12/2025 | 8.33 M | $388.91 M | -3.85% | 4.43% |
| NEXTECH INVEST, LTD. | 11/14/2025 | 7.60 M | $354.97 M | 0.00% | 4.04% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2025 | 6.22 M | $290.63 M | 2.13% | 3.31% |
| BELLEVUE GROUP AG | 11/14/2025 | 5.57 M | $260.30 M | 21.72% | 2.96% |
| STATE STREET CORP | 11/14/2025 | 5.25 M | $245.39 M | 11.35% | 2.79% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2025 | 4.78 M | $223.34 M | 1.98% | 2.54% |
| ALPHABET INC. | 11/07/2025 | 4.13 M | $193.02 M | 0.00% | 2.20% |
| BVF INC/IL | 11/14/2025 | 3.97 M | $185.63 M | -20.22% | 2.11% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 3.87 M | $180.90 M | -17.62% | 2.06% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2025 | 3.65 M | $170.47 M | 7.87% | 1.94% |
| HOLOCENE ADVISORS, LP | 11/14/2025 | 3.44 M | $160.52 M | -5.39% | 1.83% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 3.15 M | $146.93 M | 5.07% | 1.67% |
| WOODLINE PARTNERS LP | 11/14/2025 | 2.92 M | $136.17 M | 0.01% | 1.55% |
| AH CAPITAL MANAGEMENT, L.L.C. | 11/14/2025 | 2.75 M | $128.36 M | 0.00% | 1.46% |
| CASDIN CAPITAL, LLC | 11/14/2025 | 2.65 M | $123.63 M | -8.33% | 1.41% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 11/12/2025 | 2.51 M | $117.40 M | 52.42% | 1.34% |
| JPMORGAN CHASE & CO | 11/26/2025 | 2.50 M | $116.67 M | -11.94% | 1.33% |
| GENERAL ATLANTIC, L.P. | 11/13/2025 | 2.47 M | $115.56 M | 100.00% | 1.32% |
| LUNATE CAPITAL LTD | 11/20/2025 | 2.20 M | $102.56 M | 0.00% | 1.17% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 1.75 M | $81.73 M | 2.94% | 0.93% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 1.64 M | $76.37 M | 2.17% | 0.87% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 1.44 M | $67.28 M | 44.64% | 0.77% |
| MORGAN STANLEY | 11/14/2025 | 1.43 M | $67.00 M | 36.50% | 0.76% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 1.34 M | $62.36 M | 0.32% | 0.71% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.31 M | $61.19 M | 29.62% | 0.70% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 1.22 M | $57.20 M | -8.90% | 0.65% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.18 M | $55.11 M | -20.14% | 0.63% |
| UBS GROUP AG | 11/13/2025 | 1.09 M | $50.85 M | 111.55% | 0.58% |
| CALIGAN PARTNERS LP | 11/14/2025 | 1.06 M | $49.70 M | 67.12% | 0.57% |
| SIREN, L.L.C. | 11/13/2025 | 1.04 M | $48.74 M | 11.18% | 0.55% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 1.00 M | $46.70 M | 100.00% | 0.53% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 997.46 K | $46.58 M | 0.00% | 0.53% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 951.49 K | $44.43 M | 277.91% | 0.51% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2025 | 928.12 K | $43.34 M | -17.57% | 0.49% |
| CANDRIAM S.C.A. | 11/06/2025 | 868.72 K | $40.57 M | 20.74% | 0.46% |
| NORTHERN TRUST CORP | 11/14/2025 | 859.55 K | $40.14 M | 0.34% | 0.46% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 812.28 K | $37.93 M | 23.05% | 0.43% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 753.87 K | $35.21 M | 30.72% | 0.40% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 753.20 K | $35.17 M | 275.66% | 0.40% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 742.40 K | $34.67 M | 86.81% | 0.39% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 738.03 K | $34.47 M | -65.73% | 0.39% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2025 | 657.18 K | $30.69 M | -2.95% | 0.35% |
| FIRST TURN MANAGEMENT, LLC | 11/14/2025 | 643.05 K | $30.03 M | 54.73% | 0.34% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 630.00 K | $29.42 M | -47.50% | 0.33% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Revolution Medicines, Inc. institutional Ownership - FAQ's
During the previous two years, 399 institutional investors and hedge funds held shares of Revolution Medicines, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 15.66 M
FARALLON CAPITAL MANAGEMENT LLC: 14.63 M
JANUS HENDERSON GROUP PLC: 11.36 M
WELLINGTON MANAGEMENT GROUP LLP: 9.81 M
BAKER BROS. ADVISORS LP: 9.46 M
FMR LLC: 9.4 M
102.02% of Revolution Medicines, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 231.94 M shares in the last 24 months. This purchase volume represents approximately $10.83 B in transactions.